Projects per year
Search results
-
Active
An Open-label, Multicenter Trial of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Singh, M., Abdelrahim, M., Bernicker, E. H., Heyne, K., Niravath, P. A. & Zhang, J.
7/25/22 → …
Project: Clinical Trial
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R., Chen, S., Esnaola, N. F., Farach, A. M., Teh, B. S. & Zhang, J.
1/20/22 → …
Project: Clinical Trial
-
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
Bernicker, E. H., Chan, E. Y., Heyne, K., Kim, M. P., Singh, M., Sultenfuss, M. A. & Zhang, J.
9/16/21 → …
Project: Clinical Trial
-
-
Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma-CoImmune CMN-001-1
Satkunasivam, R., Singh, M. & Zhang, J.
8/26/21 → …
Project: Clinical Trial
-
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Heyne, K., Singh, M. & Zhang, J.
5/27/20 → …
Project: Clinical Trial
-
INTEGRATION OF IMMUNOTHERAPY INTO ADJUVANT THERAPY FOR RESECTED NSCLC: ALCHEMIST CHEMO-IO (ACCIO)
3/6/20 → 3/5/45
Project: Non Profit
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
CDX-1140 : A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies
Abdelrahim, M., Bernicker, E. H., Heyne, K., Singh, M. & Zhang, J.
6/19/19 → …
Project: Clinical Trial
-
A151216 - Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery ALCHEMIST
Bernicker, E. H., Darcourt, J., Heyne, K., Singh, M. & Zhang, J.
8/6/15 → …
Project: Clinical Trial
-
Not started
-
A Randomized, Open-label, Phase II Study of Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Subjects With Resectable Non-small Cell Lung Cancer (CANOPY-N)
Bernicker, E. H., Barrios, R., Chan, E. Y., Chang, J. C., Heyne, K., Kim, M. P., Niravath, P. A., Singh, M. & Zhang, J.
Project: Clinical Trial
-
Phase 3 Study of Sacituzumab Govitecan vs Physician's Choice in Subjects With Hormonal Receptor-Positive Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer Who Have Failed at Least 2 Prior Chemotherapy Regimens
Niravath, P. A., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Singh, M. & Zhang, J.
Project: Clinical Trial
-
NRG-LU005
Zhang, J., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Farach, A. M., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
Lung COPD Progressive
Chang, J. C., Bernicker, E. H., Chen, S., El-Zein, R., Heyne, K., Niravath, P. A. & Zhang, J.
Project: Clinical Trial
-
Phase II Window of Opportunity Trial of Stereotactic Body Radiation Therapy and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer and Metastatic Non-Small Cell Lung Cancer Followed by Pembrolizumab
Chang, J. C., Bernicker, E. H., Butler, E. B., Chan, E. Y., Farach, A. M., Gupta, N., Heyne, K., Kopas, L., Niravath, P. A., Singh, M., Sultenfuss, M. A., Teh, B. S. & Zhang, J.
Project: Clinical Trial
-
A Phase III, Open-Label, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Best Supportive Care Following Adjuvant Cisplatin-Based Chemotherapy in Patients With Completely Resected Stage IB-IIIA
Bernicker, E. H., Heyne, K., Singh, M. & Zhang, J.
Project: Clinical Trial
-
Lung Retrospective Protocol
Chang, J. C., Bernicker, E. H., Heyne, K., Niravath, P. A. & Zhang, J.
Project: Clinical Trial
-
Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.
Li, Z., Bernicker, E. H., Chang, J. C., Darcourt, J., Pingali, S. R., Sahay, S., Shah, S., Singh, M., Zhang, J., Zhou, S. & Zu, Y.
Project: Clinical Trial
-
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Heyne, K., Chang, J. C., Darcourt, J., Niravath, P. A., Singh, M. & Zhang, J.
Project: Clinical Trial
-
A Study of Zolbetuximab Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Abdelrahim, M., Bernicker, E. H., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
Project: Clinical Trial
-
Phase 3, Randomized, Open-Label Study to Compare Ociperlimab (BGB-A1217) Plus Tislelizumab (BGB-A317) Plus Concurrent Chemoradiotherapy (cCRT) Followed by Ociperlimab Plus Tislelizumab or Tislelizumab Plus cCRT Followed by Tislelizumab Versus cCRT Followed by Durvalumab in Previously Untreated, Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Bernicker, E. H., Singh, M. & Zhang, J.
Project: Clinical Trial